• Exchange: Natl India
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharmaceuticals

Morepen Laboratories Ltd

+ Add to Watchlist


4.15 INR 0.05 1.22%

As of 07:32:16 ET on 04/17/2014.

Snapshot for Morepen Laboratories Ltd (MORE)

Open: 4.00 Day's Range: 4.00 - 4.20 Volume: 191,286
Previous Close: 4.10 52wk Range: 2.05 - 5.79 1-Yr Rtn: +48.21%

Stock Chart for MORE

No chart data available.
  • MORE:IN 4.15
  • 1D
  • 1M
  • 1Y
Interactive MORE Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MORE

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SENSEX -
Earnings Per Share (ttm) -0.5980
Est. EPS -
Est. PEG Ratio -
Market Cap (M INR) 1,010.53
Shares Outstanding (M) 243.50
30 Day Average Volume 393,214
Price/Book (mrq) 0.6225
Price/Sale (ttm) 0.5144
Dividend Indicated Gross Yield -%
Cash Dividend (INR) 0.6000
Dividend Ex-Date 09/18/2002
5 Year Dividend Growth -
Next Earnings Announcement 05/13/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MORE

No data available

Company Profile & Key Executives for MORE

Morepen Laboratories Limited develops, manufactures and markets generic drugs and pharmaceutical formulations for domestic and international customers. The Company's products are available in a variety of formulations, including tablets, capsules, injections, ointments, syrups, and powders. Morepen's products include Loratadine, Fluvastatin, Montelukast, and Fexofenadine.

Sushil SuriChairman/Managing DirectorAjay Kumar SharmaCFO/Compliance Officer
Arun Kumar SinhaExecutive DirectorSanjay SharmaExecutive Director
More Company Profile & Key Executives for MORE

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Links
sec ||= nil